These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23170301)

  • 1. [Pharmacological treatment of schizoaffective disorder, schizophreniform disorder and brief psychotic disorder].
    Rebok F
    Vertex; 2012; 23(104):287-98. PubMed ID: 23170301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics cause an acute increase in cutaneous hand blood flow in patients with schizophrenia and schizoaffective disorder.
    Blessing E; Kader L; Arpandy R; Ootsuka Y; Blessing WW; Pantelis C
    Aust N Z J Psychiatry; 2011 Aug; 45(8):646-53. PubMed ID: 21870922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What we know and what we don't know about the treatment of schizoaffective disorder.
    Murru A; Pacchiarotti I; Nivoli AM; Grande I; Colom F; Vieta E
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):680-90. PubMed ID: 21565468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
    McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
    J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the treatment of schizoaffective disorder.
    McElroy SL; Keck PE; Strakowski SM
    J Clin Psychiatry; 1999; 60 Suppl 5():16-21; discussion 22. PubMed ID: 10192403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the pharmacologic treatment of schizoaffective disorder.
    Keck PE; McElroy SL; Strakowski SM
    J Clin Psychiatry; 1996; 57 Suppl 9():41-8. PubMed ID: 8823349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
    Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of schizoaffective disorder - a challenge for evidence-based psychiatry.
    Jäger M; Becker T; Weinmann S; Frasch K
    Acta Psychiatr Scand; 2010 Jan; 121(1):22-32. PubMed ID: 19570108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic treatment of schizoaffective disorder.
    Keck PE; McElroy SL; Strakowski SM; West SA
    Psychopharmacology (Berl); 1994 May; 114(4):529-38. PubMed ID: 7855214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological approaches to acute psychoses].
    Poirier MF
    Encephale; 1999 Nov; 25 Spec No 3():33-9. PubMed ID: 10598292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tunisian mothers' beliefs about their child's first psychotic episode].
    Bourgou S; Halayem S; Bouden A; Halayem MB
    Encephale; 2012 Dec; 38(6):473-9. PubMed ID: 23200613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment guidelines for non-schizophrenic psychotic disorders?].
    Jäger M; Frasch K; Weinmann S; Becker T
    Psychiatr Prax; 2007 Nov; 34(8):370-6. PubMed ID: 17806003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.